Acupuncture for Female With Non-cyclic Chronic Pelvic Pain
Efficacy of Acupuncture for Female With Non-cyclic Chronic Pelvic Pain: a Three-armed Randomized Controlled Trial
1 other identifier
interventional
150
0 countries
N/A
Brief Summary
Chronic pelvic pain (CPP) is one of the common symptoms of women at childbearing age. The aim of this study is to assess the efficacy of acupuncture for female with non-cyclic chronic pelvic pain. A three-arm randomized controlled trial (RCT) using acupuncture, sham acupuncture and waiting list with a total sample of 150 will be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2020
CompletedFirst Posted
Study publicly available on registry
September 17, 2020
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedNovember 23, 2021
November 1, 2021
10 months
September 6, 2020
November 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change from baseline of the mean score in the past week of the Visual Analogue Scale
The scores of the Visual Analogue Scale range from 0 to 10,higher scores mean a worse outcome.
Week 6, 18 and 30
Secondary Outcomes (10)
The change from baseline of the Brief Pain Inventory score
Week 6, 18 and 30
The change from baseline of the pain severity score of the Brief Pain Inventory
Week 6, 18 and 30
The change from baseline of the pain interference score of the Brief Pain Inventory
Week 6, 18 and 30
The proportion of patients with decrease of 0.6 score or more from baseline of the pain interference score of the Brief Pain Inventory
Week 6, 18 and 30
The proportion of patients with decrease of 20% or more from baseline of the pain severity score of the Brief Pain Inventory
Week 6, 18 and 30
- +5 more secondary outcomes
Other Outcomes (4)
Blinding assessment
Week 6
Safety assessment
Week 0 to 30
Expectation of improvement assessment
Baseline
- +1 more other outcomes
Study Arms (3)
Acupuncture group
EXPERIMENTALFor acupuncture group, sterile adhesive pads will be placed after skin disinfection on the acupoints. Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) will be inserted through the pads. The participants will be treated three times a week, on alternate days, for 6 successive weeks; 18 sessions for each patient in total.
Sham acupuncture group
SHAM COMPARATORFor the sham acupuncture group, aterile adhesive pads will be placed after skin disinfection on the acupoints and needles with a blunt tip will be inserted at the same acupoints in the acupuncture group without penetrating the skin.No manipulation of needles will be conducted. The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.
Waiting list group
NO INTERVENTIONFor the waiting list group, patients will receive no treatment in the first 6 weeks and will receive the same treatment used in the acupuncture group according to patients' preference.
Interventions
Sterile adhesive pads will be placed after skin disinfection on the acupoints. Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) will be inserted through the pads by the needles (0.30mm in diameter, 40 mm in length, Hwato Brand, Suzhou Medical Appliance Factory, China) to a depth of 25-30mm. Yintang (GV4) will be inserted through the pads by the needle (0.30mm in diameter, 25mm in length, Hwato Brand, Suzhou Medical Appliance Factory, China) to a depth of 10-15mm. The needles at all points will be lightly lifting, thrusting, and twirling every 10 minutes during each session with the sensation of sourness, achiness, heaviness and numbness (deqi). The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.
Sterile adhesive pads will be placed after skin disinfection on the acupoints. Needles (0.30 mm in diameter, 25 mm in length) with a blunt tip will be inserted at the Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) without penetrating the skin. The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.
Eligibility Criteria
You may qualify if:
- Meet the diagnostic criteria of non-cyclic CPP.
- Age 18 to 50 years.
- Have moderate to severe pain in pelvis, anterior abdominal wall, lower back, or buttocks lasting at least six months.
- The mean degree of pelvic pain in the past week rated by Visual Analogue Scale is ≥40 scores.
- Sign informed consent and participate in the study voluntarily.
You may not qualify if:
- Have endometriosis (including adenomyosis), ovarian cyst (larger than 3cm), hysteromyoma (larger than 3cm), severe pelvic adhesion, pelvic malignant tumor (relevant examination must be within the last 6 months).
- Have acute pelvic/urinary tract infection.
- Have pain after pelvic surgery.
- Have recurrent gastrointestinal or bladder diseases such as irritable bowel syndrome, interstitial cystitis / bladder pain syndrome, etc.
- During pregnancy or in lactation or have a pregnancy plan within 8 months.
- Have heart, lung, liver, kidney, mental disorders or cognitive dysfunction.
- Have acupuncture treatment in recent 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zhishun Liu, PhD
Guang'an men hospital, China Academy of Chinese Medical Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Participants in the acupuncture and sham acupuncture will be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
September 6, 2020
First Posted
September 17, 2020
Study Start
December 1, 2021
Primary Completion
September 30, 2022
Study Completion
December 31, 2023
Last Updated
November 23, 2021
Record last verified: 2021-11